# Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)

> **NCT01376271** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 600 (actual)

## Conditions studied

- Social Phobia

## Interventions

- **DRUG:** Paroxetine

## Key facts

- **NCT ID:** NCT01376271
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2014-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376271, "Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01376271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*